G
Gabriela Stoppe
Researcher at University of Basel
Publications - 88
Citations - 2226
Gabriela Stoppe is an academic researcher from University of Basel. The author has contributed to research in topics: Dementia & Private practice. The author has an hindex of 26, co-authored 84 publications receiving 2107 citations. Previous affiliations of Gabriela Stoppe include University of Göttingen & University Hospital of Basel.
Papers
More filters
Journal ArticleDOI
Sleep-wake cycles and cognitive functioning in schizophrenia
Vivien Bromundt,Matthias Köster,Angela Georgiev-Kill,Klaus Opwis,Anna Wirz-Justice,Gabriela Stoppe,Christian Cajochen +6 more
TL;DR: Consolidated circadian rhythms and sleep may be a prerequisite for adequate cognitive functioning in individuals with schizophrenia.
Journal ArticleDOI
Access to diagnostic evaluation and treatment for dementia in Europe.
Gunhild Waldemar,Kieu T.T. Phung,Alistair Burns,Jean Georges,Finn Ronholt Hansen,S Iliffe,Christine Marking,Marcel G. M. Olde Rikkert,Jacques Selmes,Gabriela Stoppe,Norman Sartorius +10 more
TL;DR: A multidisciplinary approach based on close collaboration between GPs and specialised memory clinics may be the ideal model for early accurate diagnosis and subsequently early pharmacological and psychosocial interventions.
Journal ArticleDOI
Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer Disease
Ulrich Finckh,Heinz Von Der Kammer,Joachim Velden,Tiana Michel,Barbara Andresen,Amy Deng,Jun Zhang,Tomas Müller-Thomsen,Kathrin Zuchowski,Gunnar Menzer,Ulrike Mann,Andreas Papassotiropoulos,Reinhard Heun,Jan Zurdel,Frederik Holst,Luisa Benussi,Gabriela Stoppe,Jochen Reiss,André R. Miserez,Hannes B. Staehelin,G. William Rebeck,Bradley T. Hyman,Giuliano Binetti,Christoph Hock,John H. Growdon,Roger M. Nitsch +25 more
TL;DR: CST3 is a susceptibility gene for late-onset AD, especially in patients aged 75 years and older, and to the authors' knowledge, CST3 B is the first autosomal recessive risk allele in late-ONSet AD.
Journal ArticleDOI
Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration.
J. Staedt,Gabriela Stoppe,A. Kögler,H. Riemann,Göran Hajak,D. L. Munz,Dieter Emrich,E. Rüther +7 more
TL;DR: The results indicate that NMS is related to a decrease of central D2-receptor occupancy, with a lower [123I]IBZM binding in the striatal structures compared to controls.
Journal ArticleDOI
Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus).
TL;DR: The results indicate a loss of central D2 receptors in PMS, which is consistent withperiodic movements in sleep disturbances.